AIM ImmunoTech Inc – Filings and Transcripts

NYSE American: AIM
Share price (10/21/26): $0.17
Market cap (10/21/26): $6.782 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Late quarterly filing notification for Q3 2025

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Prospectus supplement

Initial registration of new securities

Prospectus supplement for primary offering

Ownership Filter

Equels Thomas K

Equels Thomas K

Equels Thomas K

Equels Thomas K

Intracoastal Capital, LLC

News Filter

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Material Definitive Agreement, Termination of Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Biodefense Is Force Protection: Ready Today, Prepared for Tomorrow

Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness